This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

7 Under-$10 Stocks Rising on Explosive Volume

Today's Range: $2.93-$3.00

52-Week Range: $1.28-$5.19

Volume: 398,000

Three-Month Average Volume: 1.28 million

This stock is trending higher ahead of a data release for the results from a 4 key Phase II trials for its primary drug candidate, Zerenex. That data is expected to be released in the next several weeks.

From a technical perspective, KERX is bouncing higher here right off some near-term support at $2.80 with light volume. This action is quickly pushing KERX within range of triggering a major breakout trade. That trade will hit once KERX manages to clear $3 to $3.08 with high volume. If those levels get taken out, then KERX will have nothing but a gap down zone above it for resistance, since the stock gapped down in April from $5 to below $1.75.

Traders should now look for long-biased trades in KERX as long as it's trending above its 50-day at $2.68, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.28 million shares. If that breakout triggers soon, then KERX will set up to re-fill some of that massive gap from April. Some possible upside targets are $4 to $5 in the near future.

Progenics Pharmaceuticals (PGNX)

This is a biopharmaceutical company, which develops and commercializes innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. This stock is trading up 6.6% to $2.25 in recent trading.

Today's Range: $2.03-$2.52

52-Week Range: $1.41-$11.34

Volume: 2.47 million

Three-Month Average Volume: 263,297

Shares of PGNX are spiking notably higher today after the company priced its underwritten public offering of 11 million shares of common stock at $2 per share.

From a technical perspective, PGNX is bouncing higher here right off some near-term support at $2 with heavy upside volume. This move is quickly pushing PGNX within range of triggering a near-term breakout trade. That trade will hit once PGNX manages to take out some near-term overhead resistance at $2.52 to its 50-day at $2.68 with high volume.

4 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7870 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs